Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,163 INR | -1.16% | -6.95% | +4.44% |
Business Summary
Number of employees: 16,167
Sales per Business
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Branded Generics
53.8
%
| 30,028 | 51.5 % | 33,597 | 53.8 % | +11.88% |
Active Pharmaceutical Ingredients
24.4
%
| 15,132 | 26.0 % | 15,217 | 24.4 % | +0.56% |
Generics
21.2
%
| 12,504 | 21.4 % | 13,255 | 21.2 % | +6.00% |
Miscellaneous
0.5
%
| 300 | 0.5 % | 298 | 0.5 % | -0.57% |
Export Incentives
0.1
%
| 302 | 0.5 % | 59 | 0.1 % | -80.34% |
Sundry Balances Written Back
0.0
%
| 32 | 0.1 % | 17 | 0.0 % | -46.06% |
Sales per region
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
India
52.3
%
| 30,112 | 51.7 % | 32,655 | 52.3 % | +8.44% |
Americas
10.2
%
| 6,707 | 11.5 % | 6,367 | 10.2 % | -5.07% |
Europe
9.3
%
| 5,439 | 9.3 % | 5,783 | 9.3 % | +6.32% |
Asia (excluding India)
7.8
%
| 4,615 | 7.9 % | 4,885 | 7.8 % | +5.84% |
Africa
7.6
%
| 4,754 | 8.2 % | 4,769 | 7.6 % | +0.31% |
United Kingdom
4.8
%
| 2,597 | 4.5 % | 2,998 | 4.8 % | +15.44% |
Australasia
4.4
%
| 2,476 | 4.2 % | 2,777 | 4.4 % | +12.17% |
Commonwealth of Independent States
3.5
%
| 1,598 | 2.7 % | 2,210 | 3.5 % | +38.29% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 68 | 80-04-01 | |
Pranay Godha
CEO | Chief Executive Officer | 51 | 03-04-15 |
Chairman | 77 | 75-10-30 | |
Chief Tech/Sci/R&D Officer | 50 | 23-10-15 | |
Chief Investment Officer | - | - | |
Ashok Kumar
CTO | Chief Tech/Sci/R&D Officer | 70 | 00-09-05 |
Anil Pareek
CTO | Chief Tech/Sci/R&D Officer | 67 | 00-09-10 |
Compliance Officer | 64 | 93-09-19 | |
Sanjay Kapadia
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | 55 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 77 | 75-10-30 | |
Director/Board Member | 76 | 11-08-15 | |
Pranay Godha
CEO | Chief Executive Officer | 51 | 03-04-15 |
Chief Executive Officer | 68 | 80-04-01 | |
Manisha Premnath
BRD | Director/Board Member | 50 | 14-09-20 |
Director/Board Member | 69 | 22-10-19 | |
Director/Board Member | 78 | 19-03-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 253,704,218 | 132,593,199 ( 52.26 %) | 0 | 52.26 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
UNICHEM LABORATORIES LIMITED 52.67% | 37,081,011 | 52.67% | 261,498,627 $ |
LYKA LABS LIMITED 36.34% | 12,024,923 | 36.34% | 17,388,159 $ |
Company contact information
Ipca Laboratories Ltd.
125, Kandivli Industrial Estate Kandivili West
400067, Mumbai
+91 22 6647 4444
http://www.ipca.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.68% | 3.46B | |
+42.69% | 750B | |
+34.11% | 606B | |
-6.87% | 356B | |
+18.74% | 326B | |
+6.76% | 286B | |
+18.08% | 246B | |
-3.44% | 213B | |
+11.35% | 213B | |
+2.64% | 167B |
- Stock Market
- Equities
- IPCALAB Stock
- Company Ipca Laboratories Limited